These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 6876350)
1. Leads from the MMWR. Toxic-shock syndrome in a patient using a continuous subcutaneous insulin infusion pump--Idaho. JAMA; 1983 Sep; 250(9):1134-5. PubMed ID: 6876350 [No Abstract] [Full Text] [Related]
2. Toxic-shock syndrome in a patient using a continuous subcutaneous insulin infusion pump--Idaho. Centers for Disease Control (CDC) MMWR Morb Mortal Wkly Rep; 1983 Aug; 32(31):404-6, 412. PubMed ID: 6410172 [No Abstract] [Full Text] [Related]
3. Toxic shock syndrome from Staphylococcus aureus infection at insulin pump infusion sites. Report of two cases. Tanner MH; Liljenquist JE JAMA; 1988 Jan; 259(3):394-5. PubMed ID: 3336164 [TBL] [Abstract][Full Text] [Related]
4. Use of the insulin pump in children. Cornwell S; MacDonald MJ Prim Care; 1983 Dec; 10(4):723-50. PubMed ID: 6371865 [TBL] [Abstract][Full Text] [Related]
5. [Hypoglycemia in patients treated with an external insulin pump]. Laurent JC; Waeber G; Ruiz J; Carron PN Rev Med Suisse; 2011 Jan; 7(278):166-9. PubMed ID: 21400952 [TBL] [Abstract][Full Text] [Related]
6. Cellulitis caused by Rhizomucor pusillus in a diabetic patient receiving continuous insulin infusion pump therapy. Wickline CL; Cornitius TG; Butler T South Med J; 1989 Nov; 82(11):1432-4. PubMed ID: 2814631 [TBL] [Abstract][Full Text] [Related]
11. Insulin pump therapy (continuous subcutaneous insulin infusion). White RD Prim Care; 2007 Dec; 34(4):845-71, vii. PubMed ID: 18061820 [TBL] [Abstract][Full Text] [Related]
12. Update: deaths among patients using continuous subcutaneous insulin infusion pumps--United States. Centers for Disease Control (CDC) MMWR Morb Mortal Wkly Rep; 1982 Nov; 31(46):625-6. PubMed ID: 6817073 [No Abstract] [Full Text] [Related]
13. Lower rate of initial failures and reduced occurrence of adverse events with a new catheter model for continuous subcutaneous insulin infusion: prospective, two-period, observational, multicenter study. Renard E; Guerci B; Leguerrier AM; Boizel R; Diabetes Technol Ther; 2010 Oct; 12(10):769-73. PubMed ID: 20809682 [TBL] [Abstract][Full Text] [Related]
14. Needle detachment from the Sure-T infusion set in two young children with diabetes mellitus (DM) treated with continuous subcutaneous insulin infusion (CSII) and unexplained hyperglycaemia. Massa G; Gys I; Eyndt AO; Wauben K; Vanoppen A J Pediatr Endocrinol Metab; 2015 Jan; 28(1-2):237-9. PubMed ID: 25153227 [TBL] [Abstract][Full Text] [Related]
15. Glycemic control in pregnant diabetic women using a continuous subcutaneous insulin infusion pump. Cohen AW; Liston RM; Mennuti MT; Gabbe SG J Reprod Med; 1982 Oct; 27(10):651-4. PubMed ID: 7175835 [TBL] [Abstract][Full Text] [Related]
16. When your patient is on an insulin pump. Robertson C RN; 1998 Mar; 61(3):30-3; quiz 34. PubMed ID: 9544091 [No Abstract] [Full Text] [Related]
18. Best Ways and Practices to Avoid Insulin Pump Catheter Occlusions. Slover RH Diabetes Technol Ther; 2016 Mar; 18(3):118-9. PubMed ID: 26950802 [No Abstract] [Full Text] [Related]
19. [Treatment of diabetics with the Auto-syringe pump for the continuous infusion of insulin by the subcutaneous route]. Costa Gil JE; Galloway JA; Wentworth SM Rev Clin Esp; 1982 Mar; 164(6):377-81. PubMed ID: 7051202 [No Abstract] [Full Text] [Related]
20. [What is the future of continuous insulin infusion by peritoneal route?]. Selam JL; Mirouze J Diabete Metab; 1984 Sep; 10(3):221-2. PubMed ID: 6489579 [No Abstract] [Full Text] [Related] [Next] [New Search]